Charukesi Chandrasekaran
Psychiatry · Beaumont, TXNPI 1508173170
Payments from drug & device makers
Across 451 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$609
- Corium, LLC$537
- Otsuka America Pharmaceutical, Inc.$447
- Johnson & Johnson$424
- Lundbeck LLC$389
- plus $3K from 26 others
What the payments were for
- Food & beverage$7,445100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 143 | $1,670 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $609 |
| Corium, LLC | 23 | $537 |
| Otsuka America Pharmaceutical, Inc. | 31 | $447 |
| Johnson & Johnson | 25 | $424 |
| Lundbeck LLC | 21 | $389 |
| Sunovion Pharmaceuticals Inc. | 25 | $320 |
| Neurocrine Biosciences, Inc. | 16 | $290 |
| Alkermes, Inc. | 15 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $253 |
| E.r. Squibb & Sons, L.L.C. | 12 | $240 |
| Supernus Pharmaceuticals, Inc. | 11 | $239 |
| Neos Therapeutics, LP | 11 | $216 |
| Ironshore Pharmaceuticals Inc. | 12 | $210 |
| Brainsway USA Inc | 2 | $167 |
| Merck | 12 | $162 |
| Tris Pharma Inc | 9 | $159 |
| Boston Scientific | 1 | $158 |
| Almatica Pharma LLC | 7 | $134 |
| Noven Therapeutics, LLC | 6 | $101 |
| Idorsia Pharmaceuticals US Inc | 5 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Jazz Pharmaceuticals Inc. | 3 | $56 |
| Bausch Health US, LLC | 3 | $48 |
| Axsome Therapeutics, Inc. | 3 | $47 |
| Neuronetics, Inc. | 2 | $22 |
| GRT US Holding, Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
How this compares
$7,445 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 11 | $18,301 |
| Lisdexamfetamine Dimesylate | 11 | $3,151 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $1,073 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $735 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $511 |
| Gabapentin | 20 | $462 |
| Mirtazapine | 12 | $423 |
| Buspirone Hcl | 36 | $421 |
| Methylphenidate Hcl | 18 | $361 |
| Clonazepam | 40 | $354 |
| Bupropion XlBupropion Hcl | 25 | $337 |
| Alprazolam | 42 | $192 |
| Escitalopram Oxalate | 14 | $151 |
| Fluoxetine Hcl | 12 | $140 |
| Temazepam | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $609 | $18,30111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Beaumont
- Jason MensahBeaumont$10.3M
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
- Sejal MehtaPlano$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.